Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

strides arcolab international limited - eptifibatid - raztopina za infundiranje - eptifibatid 0,75 mg / 1 ml - eptifibatid

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

strides arcolab international limited - eptifibatid - raztopina za injiciranje - eptifibatid 2 mg / 1 ml - eptifibatid

União Europeia - esloveno - EMA (European Medicines Agency)

sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antitrombotična sredstva - duoplavin je indiciran za sekundarno preprečevanje aterotrombotičnih dogodkov pri odraslih bolnikih, ki že jemljejo klopidogrel in acetilsalicilno kislino (asa). duoplavin is a fixed-dose combination medicinal product for continuation of therapy in:non st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention (pci);st segment elevation acute myocardial infarction (stemi) in patients undergoing a stent placement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. za nadaljnje informacije, prosimo, preberite razdelek 5.

União Europeia - esloveno - EMA (European Medicines Agency)

teva pharma b.v. - ibandronska kislina - breast neoplasms; neoplasm metastasis; fractures, bone; osteoporosis, postmenopausal - zdravila za zdravljenje bolezni kosti - ibandronic acid 50mgibandronic kislina teva je indicirano za preprečevanje skeletne dogodkov (patološki zlomi, kosti zapleti, ki zahtevajo radioterapija ali kirurški poseg) pri bolnikih z rakom dojk in kostni zasevki. ibandronic acid 150mgtreatment of osteoporosis in postmenopausal women at increased risk of fracture. zmanjšanje tveganja za zlome vretenc je bilo dokazano, učinkovitosti na vratu femoralne zlome ni bila ugotovljena.

União Europeia - esloveno - EMA (European Medicines Agency)

mylan pharmaceuticals limited - zoledronska kislina - zlomi, kosti - zdravila za zdravljenje bolezni kosti - preprečevanje skeletne dogodki, povezani (patološki zlomi, hrbtenjača, stiskanje, sevanja ali operacijo na kosti, ali tumor povzroča hypercalcaemia) pri odraslih bolnikih z napredovalim malignancies, ki vključujejo kosti;zdravljenje odraslih bolnikov z tumor povzroča hypercalcaemia (tih).

União Europeia - esloveno - EMA (European Medicines Agency)

biokema anstalt - goste koncentrirani laktoserum, ki vsebuje specifične imunoglobuline g proti adhezinu f5 (k99) e. coli - imunologija za bovidae - teleta, novorojenček manj kot 12 let starosti - zmanjšanje smrtnosti zaradi enterotoksikoze, povezane z e.. coli f5 (k99) adhezin v prvih dneh življenja kot dopolnilo kolostrumu od jezu.

União Europeia - esloveno - EMA (European Medicines Agency)

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - imunologija za suidae - prašiči - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

União Europeia - esloveno - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - prašiči - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ebewe pharma - folinska kislina - raztopina za injiciranje/infundiranje - folinska kislina 10 mg / 1 ml - kalcijev folinat

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ebewe pharma - folinska kislina - raztopina za injiciranje/infundiranje - folinska kislina 10 mg / 1 ml - kalcijev folinat